20011040|t|Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.
20011040|a|BACKGROUND: A hallmark of the prion diseases is the conversion of the host-encoded cellular prion protein (PrP(C)) into a disease related, alternatively folded isoform (PrP(Sc)). The accumulation of PrP(Sc) within the brain is associated with synapse loss and ultimately neuronal death. Novel therapeutics are desperately required to treat neurodegenerative diseases including the prion diseases. PRINCIPAL FINDINGS: Treatment with glimepiride, a sulphonylurea approved for the treatment of diabetes mellitus, induced the release of PrP(C) from the surface of prion-infected neuronal cells. The cell surface is a site where PrP(C) molecules may be converted to PrP(Sc) and glimepiride treatment reduced PrP(Sc) formation in three prion infected neuronal cell lines (ScN2a, SMB and ScGT1 cells). Glimepiride also protected cortical and hippocampal neurones against the toxic effects of the prion-derived peptide PrP82-146. Glimepiride treatment significantly reduce both the amount of PrP82-146 that bound to neurones and PrP82-146 induced activation of cytoplasmic phospholipase A(2) (cPLA(2)) and the production of prostaglandin E(2) that is associated with neuronal injury in prion diseases. Our results are consistent with reports that glimepiride activates an endogenous glycosylphosphatidylinositol (GPI)-phospholipase C which reduced PrP(C) expression at the surface of neuronal cells. The effects of glimepiride were reproduced by treatment of cells with phosphatidylinositol-phospholipase C (PI-PLC) and were reversed by co-incubation with p-chloromercuriphenylsulphonate, an inhibitor of endogenous GPI-PLC. CONCLUSIONS: Collectively, these results indicate that glimepiride may be a novel treatment to reduce PrP(Sc) formation and neuronal damage in prion diseases.
20011040	0	11	Glimepiride	Chemical	MESH:C057619
20011040	38	42	PrPc	Gene	5621
20011040	90	104	prion mediated	Disease	MESH:D017096
20011040	105	118	neurotoxicity	Disease	MESH:D020258
20011040	164	178	prion diseases	Disease	MESH:D017096
20011040	226	239	prion protein	Gene	5621
20011040	241	247	PrP(C)	Gene	5621
20011040	303	310	PrP(Sc)	Gene	19122
20011040	333	340	PrP(Sc)	Gene	19122
20011040	377	389	synapse loss	Disease	MESH:D016388
20011040	405	419	neuronal death	Disease	MESH:D009410
20011040	474	500	neurodegenerative diseases	Disease	MESH:D019636
20011040	515	529	prion diseases	Disease	MESH:D017096
20011040	566	577	glimepiride	Chemical	MESH:C057619
20011040	581	594	sulphonylurea	Chemical	MESH:D013453
20011040	625	642	diabetes mellitus	Disease	MESH:D003920
20011040	667	673	PrP(C)	Gene	5621
20011040	694	699	prion	Disease	MESH:D017096
20011040	700	708	infected	Disease	MESH:D007239
20011040	758	764	PrP(C)	Gene	5621
20011040	795	802	PrP(Sc)	Gene	19122
20011040	807	818	glimepiride	Chemical	MESH:C057619
20011040	837	844	PrP(Sc)	Gene	19122
20011040	864	878	prion infected	Disease	MESH:D017096
20011040	900	905	ScN2a	CellLine	CVCL:6268
20011040	907	910	SMB	CellLine	CVCL:S863
20011040	915	920	ScGT1	CellLine	CVCL:6267
20011040	929	940	Glimepiride	Chemical	MESH:C057619
20011040	1023	1028	prion	Disease	MESH:D017096
20011040	1056	1067	Glimepiride	Chemical	MESH:C057619
20011040	1199	1217	phospholipase A(2)	Gene	5319
20011040	1219	1226	cPLA(2)	Gene	5321
20011040	1250	1268	prostaglandin E(2)	Chemical	MESH:D015232
20011040	1293	1308	neuronal injury	Disease	MESH:D009410
20011040	1312	1326	prion diseases	Disease	MESH:D017096
20011040	1373	1384	glimepiride	Chemical	MESH:C057619
20011040	1409	1459	glycosylphosphatidylinositol (GPI)-phospholipase C	Gene	
20011040	1474	1480	PrP(C)	Gene	5621
20011040	1541	1552	glimepiride	Chemical	MESH:C057619
20011040	1596	1632	phosphatidylinositol-phospholipase C	Gene	5335
20011040	1634	1640	PI-PLC	Gene	5335
20011040	1682	1713	p-chloromercuriphenylsulphonate	Chemical	MESH:D002731
20011040	1806	1817	glimepiride	Chemical	MESH:C057619
20011040	1853	1860	PrP(Sc)	Gene	19122
20011040	1875	1890	neuronal damage	Disease	MESH:D009410
20011040	1894	1908	prion diseases	Disease	MESH:D017096
20011040	Association	MESH:D015232	MESH:D009410
20011040	Negative_Correlation	MESH:C057619	MESH:D007239
20011040	Negative_Correlation	MESH:C057619	MESH:D017096
20011040	Negative_Correlation	MESH:C057619	19122
20011040	Association	MESH:C057619	MESH:D002731
20011040	Association	MESH:D016388	19122
20011040	Negative_Correlation	MESH:D013453	MESH:D003920
20011040	Positive_Correlation	MESH:C057619	5321
20011040	Negative_Correlation	MESH:C057619	MESH:D009410
20011040	Association	MESH:D017096	5621
20011040	Positive_Correlation	MESH:C057619	MESH:D015232
20011040	Positive_Correlation	MESH:C057619	5319
20011040	Bind	19122	5621
20011040	Association	MESH:C057619	5335
20011040	Negative_Correlation	MESH:C057619	MESH:D003920
20011040	Association	MESH:D017096	5319
20011040	Association	MESH:D015232	MESH:D017096
20011040	Negative_Correlation	MESH:C057619	MESH:D020258
20011040	Negative_Correlation	MESH:C057619	5621
20011040	Association	MESH:D017096	19122
20011040	Association	MESH:D009410	19122

